Study finds numerous drug combinations sold in India lack regulatory approval

Reuters, 12 May 2015
Author: Zeba Siddiqui
“Almost two-thirds of the drug combinations widely sold in India to fight pain, depression, and psychotic conditions lack the necessary regulatory approvals, despite some of the pills being banned internationally, a study published on Tuesday shows. India’s reputation as a reliable supplier of cheap generic medicines has taken a hit after sanctions by the United States and Britain faced by some of its largest drugmakers over violations of standard drug-making practices.”
Find article here.